Karl Ulrich Bayer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karl Ulrich Bayer has a total of 122 co-authors. Here are the top co-authors by number of shared publications:
Steven J. Coultrap
31 shared publicationsJonathan E. Tullis
Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
12 shared publicationsNicole L. Rumian
Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
12 shared publicationsOlivia R. Buonarati
Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA
10 shared publicationsCarolyn Nicole Brown
8 shared publicationsDayton J. Goodell
Department of Pharmacology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA; Program in Neuroscience, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA
7 shared publications
Latest Publications
- Open Access
- 23 September 2026
- Published by Elsevier in Molecular Cell
- Vol. 86 (19) , 4004-4017.e6
CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation
- 23 September 2026
- Published by Elsevier in Molecular Cell
- Vol. 86 (19) , 4004-4017.e6
Open AccessCaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation
- Open Access
CaMKII T286 autophosphorylation is not propagated at basal Ca 2+ levels and is required only for the induction phase of LTP
SUMMARY: The Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) and its autophosphorylation at T286 (P-T286) mediates long-term potentiation (LTP) of synaptic strength. CaMKII forms stable 12-meric holoenzymes, but exchange of its subunits is proposed to propagate the P-T286 state beyond dephosphorylation or degradation of individual subunits. However, a recent study questioned subunit exchange and instead proposed P-T286 propagation by trans -holoenzyme phosphorylation. We show here that both subunit exchange and trans -holoenzyme P-T286 can occur (although cis -holoenzyme P-T286 is much preferred), but that neither mechanism propagates P-T286 at basal cellular Ca 2+ levels (50-100 nM) in absence of further Ca 2+ -stimuli. Functionally, we show that after theta-burst stimulation (TBS), P-T286 is required only during the first minutes of LTP induction that prime for subsequent LTP expression, but neither for LTP expression itself nor for LTP maintenance. These results indicate that P-T286 of CaMKII does not self-perpetuate and does not mediate storage but computation of synaptic information.
Open AccessCaMKII T286 autophosphorylation is not propagated at basal Ca 2+ levels and is required only for the induction phase of LTP
SUMMARY: The Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) and its autophosphorylation at T286 (P-T286) mediates long-term potentiation (LTP) of synaptic strength. CaMKII forms stable 12-meric holoenzymes, but exchange of its subunits is proposed to propagate the P-T286 state beyond dephosphorylation or degradation of individual subunits. However, a recent study questioned subunit exchange and instead proposed P-T286 propagation by trans -holoenzyme phosphorylation. We show here that both subunit exchange and trans -holoenzyme P-T286 can occur (although cis -holoenzyme P-T286 is much preferred), but that neither mechanism propagates P-T286 at basal cellular Ca 2+ levels (50-100 nM) in absence of further Ca 2+ -stimuli. Functionally, we show that after theta-burst stimulation (TBS), P-T286 is required only during the first minutes of LTP induction that prime for subsequent LTP expression, but neither for LTP expression itself nor for LTP maintenance. These results indicate that P-T286 of CaMKII does not self-perpetuate and does not mediate storage but computation of synaptic information.
- Open Access
- 7 May 2026
- Published by Elsevier in Molecular Pharmacology
- Vol. 108 (5-6) , 100127
The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding
- 7 May 2026
- Published by Elsevier in Molecular Pharmacology
- Vol. 108 (5-6) , 100127
Open AccessThe CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding
- Open Access
The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding
Three recent studies claimed that induction of long-term potentiation (LTP) of synaptic strength requires structural rather than enzymatic functions of the Ca 2+ /Calmodulin(CaM)-dependent protein kinase II (CaMKII). One study utilized the CaMKII D135N mutation, which was claimed to abolish enzymatic activity without affecting the structural function, i.e. binding to GluN2B. We found here that the D135N mutant indeed abolished enzymatic kinase activity and autophosphorylation at T286 (pT286). However, D135N mutation additionally reduced binding to GluN2B and prevented persistence of co-condensation with GluN2B. Similar as with the T286A mutant, GluN2B binding of the D135N mutant could be partially rescued by AS283, an inhibitor that directly enhances GluN2B binding. This partial effect on GluN2B binding has to be taken into account when using D135N to distinguish between enzymatic versus structural functions of CaMKII. Nonetheless, as discussed here, the D135N mutant indeed supports a structural rather than enzymatic CaMKII function in LTP induction.
Open AccessThe CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding
Three recent studies claimed that induction of long-term potentiation (LTP) of synaptic strength requires structural rather than enzymatic functions of the Ca 2+ /Calmodulin(CaM)-dependent protein kinase II (CaMKII). One study utilized the CaMKII D135N mutation, which was claimed to abolish enzymatic activity without affecting the structural function, i.e. binding to GluN2B. We found here that the D135N mutant indeed abolished enzymatic kinase activity and autophosphorylation at T286 (pT286). However, D135N mutation additionally reduced binding to GluN2B and prevented persistence of co-condensation with GluN2B. Similar as with the T286A mutant, GluN2B binding of the D135N mutant could be partially rescued by AS283, an inhibitor that directly enhances GluN2B binding. This partial effect on GluN2B binding has to be taken into account when using D135N to distinguish between enzymatic versus structural functions of CaMKII. Nonetheless, as discussed here, the D135N mutant indeed supports a structural rather than enzymatic CaMKII function in LTP induction.
- Open Access
CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation
SUMMARY: Cognitive functions require synaptic plasticity, specifically long-term potentiation (LTP). LTP is thought to require CaMKII binding to the NMDA-type glutamate receptor subunit GluN2B, but this poses a major conundrum: Truncated CaMKII monomers (without the hub domain that forms 12meric holoenzymes) fail to bind GluN2B, but still potentiate synapses when made constitutively active. We hypothesized that CaMKII monomer binding to GluN2B has just eluded detection. Instead, even though full-length CaMKII monomers (with hub domain mutations) were found to indeed bind and even co-condensate with GluN2B, truncated monomers were not. Nonetheless, truncated monomers still potentiated synapses, even in neurons with GluN2B mutations that ablate CaMKII binding. However, potentiation occurred only with monomers that were made Ca 2+ -independent by artificial phosphatase-resistant thio-autophosphorylation, not by regular autophosphorylation of T286. These findings support that CaMKII binding to GluN2B is required during physiological LTP induction because it generates the phosphatase-resistant autonomous activity that mediates LTP expression.
Open AccessCaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation
SUMMARY: Cognitive functions require synaptic plasticity, specifically long-term potentiation (LTP). LTP is thought to require CaMKII binding to the NMDA-type glutamate receptor subunit GluN2B, but this poses a major conundrum: Truncated CaMKII monomers (without the hub domain that forms 12meric holoenzymes) fail to bind GluN2B, but still potentiate synapses when made constitutively active. We hypothesized that CaMKII monomer binding to GluN2B has just eluded detection. Instead, even though full-length CaMKII monomers (with hub domain mutations) were found to indeed bind and even co-condensate with GluN2B, truncated monomers were not. Nonetheless, truncated monomers still potentiated synapses, even in neurons with GluN2B mutations that ablate CaMKII binding. However, potentiation occurred only with monomers that were made Ca 2+ -independent by artificial phosphatase-resistant thio-autophosphorylation, not by regular autophosphorylation of T286. These findings support that CaMKII binding to GluN2B is required during physiological LTP induction because it generates the phosphatase-resistant autonomous activity that mediates LTP expression.
- 1 May 2025
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 36 (5)
Aβ impairs the LTP-related movement of endogenous CaMKII but not of exogenous GFP-CaMKII
Amyloid β (Aβ) inhibits hippocampal long-term potentiation (LTP; a form of synaptic plasticity thought to underly learning and memory) by inhibiting the stimulation-induced synaptic accumulation of the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII). Notably, CaMKII inhibition rescues both CaMKII movement and LTP, indicating that CaMKII mediates both LTP and the Aβ-induced LTP impairment. Somewhat counterintuitively, we found here that overexpression of GFP-CaMKII also rescued the Aβ-induced impairment of CaMKII movement. For endogenous CaMKII, we confirmed that Aβ indeed induced impairment of movement, and that previous results with live-imaging approaches were not due to Aβ-induced dissociation of the CaMKII intrabody. For exogenous GFP-CaMKII, the effect did not depend on the expression level and was thus likely caused by the N-terminal GFP label. Surprisingly, placing the GFP label instead at the C-terminus (near the association domain) still allowed CaMKII holoenzyme formation and still protected from the Aβ-induced impairment of CaMKII movement. Thus, while our method allows replacing endogenous CaMKII with similar amounts of GFP-CaMKII, our results provide a rare example for GFP-CaMKII not recapitulating the function of endogenous CaMKII.
- 1 May 2025
- Published by American Society for Cell Biology (ASCB) in Molecular Biology of the Cell
- Vol. 36 (5)
Aβ impairs the LTP-related movement of endogenous CaMKII but not of exogenous GFP-CaMKII
Amyloid β (Aβ) inhibits hippocampal long-term potentiation (LTP; a form of synaptic plasticity thought to underly learning and memory) by inhibiting the stimulation-induced synaptic accumulation of the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII). Notably, CaMKII inhibition rescues both CaMKII movement and LTP, indicating that CaMKII mediates both LTP and the Aβ-induced LTP impairment. Somewhat counterintuitively, we found here that overexpression of GFP-CaMKII also rescued the Aβ-induced impairment of CaMKII movement. For endogenous CaMKII, we confirmed that Aβ indeed induced impairment of movement, and that previous results with live-imaging approaches were not due to Aβ-induced dissociation of the CaMKII intrabody. For exogenous GFP-CaMKII, the effect did not depend on the expression level and was thus likely caused by the N-terminal GFP label. Surprisingly, placing the GFP label instead at the C-terminus (near the association domain) still allowed CaMKII holoenzyme formation and still protected from the Aβ-induced impairment of CaMKII movement. Thus, while our method allows replacing endogenous CaMKII with similar amounts of GFP-CaMKII, our results provide a rare example for GFP-CaMKII not recapitulating the function of endogenous CaMKII.
- Open Access
- 2 April 2025
- Published by Elsevier in Current Opinion in Neurobiology
- Vol. 92, 102961
CaMKII mechanisms that promote pathological LTP impairments
- 2 April 2025
- Published by Elsevier in Current Opinion in Neurobiology
- Vol. 92, 102961
Open AccessCaMKII mechanisms that promote pathological LTP impairments
- Open Access
- 12 March 2025
- Published by Elsevier in Molecular Pharmacology
- Vol. 107 (4) , 100029
The neuroprotective γ-hydroxybutyrate analog 3-hydroxycyclopent-1-enecarboxylic acid does not directly affect CaMKIIα autophosphorylation at T286 or binding to GluN2B
- 12 March 2025
- Published by Elsevier in Molecular Pharmacology
- Vol. 107 (4) , 100029
Open AccessThe neuroprotective γ-hydroxybutyrate analog 3-hydroxycyclopent-1-enecarboxylic acid does not directly affect CaMKIIα autophosphorylation at T286 or binding to GluN2B
- Open Access
Oxygen/glucose-deprivation causes long-term impairment of synaptic CaMKII movement
SUMMARY: Learning and memory are thought to require hippocampal long-term potentiation (LTP), a form of synaptic plasticity that is persistently impaired after cerebral ischemia and that requires movement of the Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) to excitatory synapses. We show here that oxygen/glucose-deprivation (OGD) in cultures hippocampal neurons causes a long-lasting impairment of CaMKII movement. Notably, CaMKII inhibition at 30 min after onset of OGD prevented the impairment in CaMKII movement. Thus, CaMKII mediates both, LTP mechanisms and their ischemia-induced impairment. These findings provide a mechanism by which ischemic conditions can impair LTP and explain how CaMKII inhibition after cerebral ischemia can prevent these LTP impairments.
Open AccessOxygen/glucose-deprivation causes long-term impairment of synaptic CaMKII movement
SUMMARY: Learning and memory are thought to require hippocampal long-term potentiation (LTP), a form of synaptic plasticity that is persistently impaired after cerebral ischemia and that requires movement of the Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) to excitatory synapses. We show here that oxygen/glucose-deprivation (OGD) in cultures hippocampal neurons causes a long-lasting impairment of CaMKII movement. Notably, CaMKII inhibition at 30 min after onset of OGD prevented the impairment in CaMKII movement. Thus, CaMKII mediates both, LTP mechanisms and their ischemia-induced impairment. These findings provide a mechanism by which ischemic conditions can impair LTP and explain how CaMKII inhibition after cerebral ischemia can prevent these LTP impairments.
- 18 November 2024
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (1) , 24-34
A revised view of the role of CaMKII in learning and memory
The Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) plays a fundamental role in learning and possibly also in memory. However, current mechanistic models require fundamental revision. CaMKII autophosphorylation at Thr286 (pThr286) does not provide the molecular basis for long-term memory, as long believed. Instead, pThr286 mediates the signal processing required for induction of several distinct forms of synaptic plasticity, including Hebbian long-term potentiation and depression and non-Hebbian behavioral timescale synaptic plasticity. We discuss (i) the molecular computations by which CaMKII supports these diverse plasticity mechanisms, (ii) alternative CaMKII mechanisms that may contribute to the maintenance phase of LTP and (iii) the relationship of these mechanisms to behavioral learning and memory.
- 18 November 2024
- Published by Springer Nature in Nature Neuroscience
- Vol. 28 (1) , 24-34
A revised view of the role of CaMKII in learning and memory
The Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) plays a fundamental role in learning and possibly also in memory. However, current mechanistic models require fundamental revision. CaMKII autophosphorylation at Thr286 (pThr286) does not provide the molecular basis for long-term memory, as long believed. Instead, pThr286 mediates the signal processing required for induction of several distinct forms of synaptic plasticity, including Hebbian long-term potentiation and depression and non-Hebbian behavioral timescale synaptic plasticity. We discuss (i) the molecular computations by which CaMKII supports these diverse plasticity mechanisms, (ii) alternative CaMKII mechanisms that may contribute to the maintenance phase of LTP and (iii) the relationship of these mechanisms to behavioral learning and memory.